Combined synopsis and solicitation
Fel d 1-specific capture and biotin-labeled detection monoclonal antibodies suitable for use in Enzyme Linked Immunosorbent Assay (ELISA/ImmunoEnzymetric Assay (IEMA)
FDARFQ125149
Food and Drug Administration, FDA Center for Biologics Evaluation and Research. Biological Product (except Diagnostic) Manufacturing.
Awarded
$100,000.00 obligated so far on USAspending
Description
As published on SAM.gov.
Purchase Fel d 1-specific capture and biotin-labeled detection monoclonal antibodies suitable for use in Enzyme Linked Immunosorbent Assay (ELISA/ImmunoEnzymetric Assay (IEMA)
8/28/2024:
Contractor Question and Government Response: Does the product need to be an existing off-the shelf material, or can it be custom-developed for this RFQ? Can the host species be rabbit?
GOVERNMENT RESPONSE: The product can be off the shelf The product should be human origin, not rabbit or mouse.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Iggenix, Inc.
- UEI
- HBP9HFYHB3Q4
- CAGE
- 8KPW3
- Vendor location
- South San Francisco, CA
- Contract
- 75F40124P00438, purchase order
- Obligated
- $100,000.00
- Actions
- 2 between September 4, 2024 and September 23, 2025
- Competition
- Competed Under SAP, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Fel D 1-Specific Human Ige Class Switched to Ige Monoclonal Antibodies
- Match
- solicitation number FDARFQ125149 equals the FPDS solicitation identifier; same sub-agency 7524 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- Howard S. Yablonhoward.yablon@fda.hhs.gov2404027630